Components of metabolic syndrome and their combinations as predictors of cardiovascular disease in Japanese patients with type 2 diabetes. Implications for improved definition. Analysis from Japan Diabetes Complications Study (JDCS)

Journal of Atherosclerosis and Thrombosis

Volumn 16, Issue 4, 2009, Pages 380-387

  Sone, Hirohito ^a   Tanaka, Sachiko ^b,c   Iimuro, Satoshi ^c   Oida, Koji ^d   Yamasaki, Yoshimitsu ^e   Oikawa, Shinichi ^f   Ishibashi, Shun ^g   Katayama, Shigehiro ^h   Ito, Hideki ⁱ   Ohashi, Yasuo ^c   Akanuma, Yasuo ^j   Yamada, Nobuhiro ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b TOKYO UNIVERSITY OF SCIENCE   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d Fukui Chuo Clinic   (Japan)

^e OSAKA UNIVERSITY   (Japan)

^f NIPPON MEDICAL SCHOOL   (Japan)

^g JICHI MEDICAL UNIVERSITY   (Japan)

^h SAITAMA MEDICAL UNIVERSITY   (Japan)

ⁱ Tokyo Metropolitan Institute of Gerontology   (Japan)

^j INSTITUTE FOR ADULT DISEASES   (Japan)

more..

Author keywords

Cardiovascular risk factors; Diabetic macroangiopathy; Dyslipidemia; Hypertension

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; INSULIN; ORAL ANTIDIABETIC AGENT; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DYSLIPIDEMIA; FEMALE; HIGH RISK PATIENT; HUMAN; HYPERGLYCEMIA; HYPERTENSION; JAPANESE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTION; REFERENCE VALUE; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE;

EID: 73249139500     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.No117     Document Type: Article

References (28)

1. Sone H, Mizuno S, Fujii H, Yoshimura Y, Yamasaki Y, Ishibashi S, Katayama S, Saito Y, Ito H, Ohashi Y, Akanuma Y, Yamada N: Japan Diabetes Complications Study: Is the diagnosis of metabolic syndrome useful for predicting cardiovascular disease in asian diabetic patients ? Analysis from the Japan Diabetes Complications Study. Diabetes Care, 2005; 28:1463-1471
2. Sone H, Tanaka S, Ishibashi S, Yamasaki Y, Oikawa S, Ito H, Saito Y, Ohashi Y, Akanuma Y, Yamada N: The new worldwide definition of metabolic syndrome is not a better diagnostic predictor of cardiovascular disease in Japanese diabetic patients than the existing definitions: additional analysis from the Japan Diabetes Complications Study. Diabetes Care, 2006; 29:145-147
3. Sone H, Tanaka S, Ishibashi S, Yamasaki Y, Oikawa S, Ito H, Saito Y, Ohashi Y, Akanuma Y, Yamada N; Japan Diabetes Comlications Study (JDCS) Group: The new worldwide definition of Metabolic syndrome is not a better diagnostic predictor of cardiovascular disease in Japanese diabetic patients than the existing definitional analysis from the Japan Diabetes Complications Study. Diabetes Care, 2006; 29:145-147
4. Cull CA, Jensen CC, Retnakaran R, Holman RR: Impact of the metabolic syndrome on macrovascular and microvascular outcomes in type 2 diabetes mellitus: United Kingdom Prospective Diabetes Study 78. Circulation, 2007; 116:2119-2126
5. Tong PC, Kong AP, So WY, Yang X, Ho CS, Ma RC, Ozaki R, Chow CC, Lam CW, Chan JC, Cockram CS: The usefulness of the International Diabetes Federation and the National Cholesterol Education Program's Adult Treatment Panel III definitions of the metabolic syndrome in predicting coronary heart disease in subjects with type 2 diabetes. Diabetes Care, 2007; 30:1206-1211
6. de Simone G, Devereux RB, Chinali M, Best LG, Lee ET, Galloway JM, Resnick HE: Prognostic impact of metabolic syndrome by different definitions in a population with high prevalence of obesity and diabetes: the Strong Heart Study. Diabetes Care, 2007; 30:1851-1856
7. Monami M, Marchionni N, Masotti G, Mannucci E: IDF and ATP-III definitions of metabolic syndrome in the prediction of all-cause mortality in type 2 diabetic patients. Diabetes Obes Metab, 2007; 9:350-353
8. Monami M, Lambertucci L, Ungar A, Pieri M, Masotti G, Marchionni N, Mannucci E: Is the third component of metabolic syndrome really predictive of outcomes in type 2 diabetic patients ? Diabetes Care, 2006; 29:2515-2517
9. Hillier TA, Rizzo JH, Pedula KL, Cauley JA, Schwartz AV, Ensrud KE, Browner WS: Increased mortality associated with the metabolic syndrome in older women with diabetes. Diabetes Care, 2005; 28:2258-2260
10. Ko GT, So WY, Chan NN, Chan WB, Tong PC, Li J, Yeung V, Chow CC, Ozaki R, Ma RC, Cockram CS, Chan JC: Prediction of cardiovascular and total mortality in Chinese type 2 diabetic patients by the WHO definition for the metabolic syndrome. Diabetes Obes Metab, 2006; 8:94-104
11. Juutilainen A, Lehto S, Rönnemaa T, Pyörälä K, Laakso M: Proteinuria and metabolic syndrome as predictors of cardiovascular death in non-diabetic and type 2 diabetic men and women. Diabetologia, 2006; 49:56-65
12. Najarian RM, Sullivan LM, Kannel WB, Wilson PW, D'Agostino RB, Wolf PA: Metabolic syndrome compared with type 2 diabetes mellitus as a risk factor for stroke: the Framingham Offspring Study. Arch Intern Med, 2006; 166:106-111
13. Guzder RN, Gatling W, Mullee MA, Byrne CD: Impact of metabolic syndrome criteria on cardiovascular disease risk in people with newly diagnosed type 2 diabetes. Diabetologia, 2006; 49:49-55
14. Mancia G, Bombelli M, Corrao G, Facchetti R, Madotto F, Giannattasio C, Trevano FQ, Grassi G, Zanchetti A, Sega R: Metabolic syndrome in the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) study: daily life blood pressure, cardiac damage, and prognosis. Hypertension, 2007; 49:40-47
15. Hanefeld M, Koehler C, Gallo S, Benke I, Ott P: Impact of the individual components of the metabolic syndrome and their different combinations on the prevalence of atherosclerotic vascular disease in type 2 diabetes: the Diabetes in Germany (DIG) study. Cardiovasc Diabetol, 2007; 26:6-13
16. Guize L, Thomas F, Pannier B, Bean K, Jego B, Benetos A: All-cause mortality associated with specific combinations of the metabolic syndrome according to recent definitions. Diabetes Care, 2007; 30:2381-2387
17. Sone H, Katagiri A, Ishibashi S, Abe R, Saito Y, Murase T, Yamashita H, Yajima Y, Ito H, Ohashi Y, Akanuma Y, Yamada N; JD Study Group: Effects of lifestyle modifications on patients with type 2 diabetes: the Japan Diabetes Complications Study (JDCS) study design, baseline analysis and three year-interim report. Horm Metab Res, 2002; 34:509-515
18. Organization WH: Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Genova, Switzerland: Department of non-communicable Disease Surveillance; 1999,
19. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Costa F; American Heart Association; National Heart, Lung, and Blood Institute: Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation, 2005; 112:2735-2752
20. Definition and the diagnostic standard for metabolic syndrome - Committee to Evaluate Diagnostic Standards for Metabolic Syndrome. Nippon Naika Gakkai Zasshi, 2005; 94:794-809
21. Alberti KG, Zimmet P, Shaw J; IDF Epidemiology Task Force Consensus Group: The metabolic syndrome - a new worldwide definition. Lancet, 2005; 366:1059-1062
22. Fujita T: The metabolic syndrome in Japan. Nature Clinical Practice, 2008; 5 Suppl 1:S15-18
23. Liu J, Grundy SM, Wang W, Smith SC Jr, Vega GL, Wu Z, Zeng Z, Wang W, Zhao D: Ten-year risk of cardiovascular incidence related to diabetes, prediabetes, and the metabolic syndrome. Am Heart J, 2007; 153:552-558
24. Mak KH, Ma S, Heng D, Tan CE, Tai ES, Topol EJ, Chew SK: Impact of sex, metabolic syndrome, and diabetes mellitus on cardiovascular events. Am J Cardiol, 2007; 100:227-233
25. Bruno G, Merletti F, Biggeri A, Bargero G, Ferrero S, Runzo C, Prina Cerai S, Pagano G, Cavallo-Perin P; Casale Monferrato Study: Metabolic syndrome as a predictor of all-cause and cardiovascular mortality in type 2 diabetes: the Casale Monferrato Study. Diabetes Care, 2004; 27:2689-2694
26. Pambianco G, Costacou T, Orchard TJ: The prediction of major outcomes of type 1 diabetes: a 12-year prospective evaluation of three separate definitions of the metabolic syndrome and their components and estimated glucose disposal rate: the Pittsburgh Epidemiology of Diabetes Complications Study experience. Diabetes Care, 2007; 30:1248-1254
27. Hunt KJ, Williams K, Hazuda HP, Stern MP, Haffner SM: The metabolic syndrome and the impact of diabetes on coronary heart disease mortality in women and men: the San Antonio Heart Study. Annals of Epidemiology, 2007; 17:870-877
28. Lee J, Ma S, Heng D, Tan CE, Chew SK, Hughes K, Tai ES: Should central obesity be an optional or essential component of the metabolic syndrome ? Ischemic heart disease risk in the Singapore Cardiovascular Cohort Study. Diabetes Care, 2007; 30:343-347